Luowo Ke (洛沃克)洛沃克
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 深圳海王药业有限公司Chinese legal name: 深圳海王药业有限公司
主要成分Active Ingredients
- 黄酮哌酯Huangtong Paizhi
药物知识说明
黄酮哌酯是一种在国家药监局注册认定的药品。该药品含有黄酮哌酯-368311d8等成分。
该药品关联的活性成分包括：黄酮哌酯Huangtong Paizhi。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：深圳海王药业有限公司Chinese legal name: 深圳海王药业有限公司。
您可以探索含有相同成分的其他药品：黄酮哌酯-368311d8成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 洛沃克) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 黄酮哌酯Huangtong Paizhi.
Manufacturers recorded for this product: 深圳海王药业有限公司Chinese legal name: 深圳海王药业有限公司.
Explore other medicines containing the same ingredient: 黄酮哌酯 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 洛沃克Recorded Chinese name: 洛沃克
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 0.1g0.1 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 深圳海王药业有限公司Chinese legal name: 深圳海王药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H44024055
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H44024055
Manufacturer
Chinese legal name: 深圳海王药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep sealed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H44024055
生产企业
深圳海王药业有限公司(国产)
适应症
1.下尿路感染性疾病(前列腺炎、膀胱炎、尿道炎等)。|2.下尿路梗阻性疾病(早、中期前列腺增生症，痉挛性、功能性尿道狭窄)。|3.下尿路器械检查后或手术后(前列腺摘除术、尿道扩张、膀胱腔内手术)。|4.尿道综合症。|5.急迫性尿失禁。
用法用量
口服:一次0.2g，一日3～4次或遵医嘱。
不良反应
个别患者可出现胃部不适、恶心、呕吐、口渴、嗜睡、视力模糊、心悸及皮疹等。
禁忌
1.胃肠道梗阻或出血、贲门失弛缓症、尿道阻塞失代偿者禁用。|2.有神经精神症状者及心、肝、肾功能严重受损者禁用。
注意事项
1.泌尿生殖道感染患者，需进行抗感染治疗。|2.青光眼、白内障及残余尿量较多者慎用。|3.勿与大量维生素C或钾盐合用。|4.司机及高空作业人员等禁用。
贮藏
密封。
规格
0.1g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.